Adlai Nortye (ANL) Cash & Equivalents (2022 - 2025)
Adlai Nortye (ANL) reported Cash & Equivalents of $8.1 million for Q4 2025, down 86.77% year-over-year from $60.9 million in Q4 2024, and down 86.77% on a QoQ basis from $60.9 million in Q2 2025.
Adlai Nortye (ANL) has 4 years of Cash & Equivalents data on file, last reported at $8.1 million in Q4 2025.
- Quarterly Cash & Equivalents fell 86.77% year-over-year to $8.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.1 million (down 86.77% YoY) and the FY2025 annual result came in at $8.1 million, down 86.77% from the prior year.
- Cash & Equivalents eased to $8.1 million in Q4 2025 per ANL's latest filing, from $60.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $98.0 million in Q2 2024 and bottomed at $8.1 million in Q4 2025.
- The 4-year median for Cash & Equivalents is $60.9 million (2024), against an average of $60.3 million.
- The widest annual swing landed in 2023, when Cash & Equivalents soared 113.98%; it then slumped 86.77% in 2025.
- Tracing ANL's Cash & Equivalents over 4 years: stood at $42.8 million in 2022, then jumped by 113.98% to $91.5 million in 2023, then sank by 33.43% to $60.9 million in 2024, then tumbled by 86.77% to $8.1 million in 2025.
- Per Business Quant, the three latest ANL Cash & Equivalents figures stand at $8.1 million (Q4 2025), $60.9 million (Q2 2025), and $60.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.06 Mn |
| Jun 30, 2025 | 60.90 Mn |
| Dec 31, 2024 | 60.90 Mn |
| Jun 30, 2024 | 97.98 Mn |
| Dec 31, 2023 | 91.49 Mn |
| Dec 31, 2022 | 42.76 Mn |